Real-life effectiveness of once-daily single-inhaler triple therapy (FF-UMEC-VI) after switching from dual therapy (ICS-LABA) in patients with symptomatic asthma: trelegy ellipta for real asthma control study
In patients with symptomatic asthma showing insufficient control, an improvement in the asthma symptoms was observed after switching to FF-UMEC-VI at the equivalent corticosteroid dose, accompanied by an improvement in FEV1.
Authors
- Tatsuo Yukawa
- Nana Yazawa
- Rinna Tei
- Yuto Goto
- Atsushi Kushima
- Ryo Arai
- Naoya Ikeda (ORCID: https://orcid.org/0000-0002-1498-8713)
- Meitetsu Masawa
- Yasuo Haruyama (ORCID: https://orcid.org/0000-0001-6865-5159)
- Yasuo Shimizu (ORCID: https://orcid.org/0000-0001-5411-7739)
- Kazuyuki Chibana
- Seiji Niho (ORCID: https://orcid.org/0000-0001-9480-5923)
- Hiroaki Okutomi (ORCID: https://orcid.org/0009-0006-5062-8527)
- Yukio Ando (ORCID: https://orcid.org/0000-0001-7115-9105)
- Akihiro Takemasa (ORCID: https://orcid.org/0009-0001-0049-7964)
- Yoshitomo Kushima
- Masahiro Amagai
- Yusuke Nakamura
- Yuka Shimizu
Institutions
- Miwa Internal Medicine Clinic (JP)
- Tochigi Medical Center (JP)
- Dokkyo Medical University (JP)
Publication Details
- Journal
- Frontiers in Allergy
- Published
- 2025-03-17
- DOI
- https://doi.org/10.3389/falgy.2025.1537501
- Primary Topic
- Asthma and respiratory diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00